Around the world, people are struggling with mental health issues that don’t respond to conventional treatments. The impact of this epidemic on societies, families, and individuals is immeasurable. Ampa translates fundamental neuroscience research into practical tools that people can use to recover their mental health.
Our mission is to help a billion people reach remission from mental and neurological disorders.
At Ampa, we’re all gathered around a common vision to bring this powerful treatment to every person who needs it. To bring our vision to life, we’ve assembled a team of hardworking and talented individuals who are passionate about mental health and dedicated to the mission before us. Our advisors include some of the world’s most experienced TMS researchers, engineers, and clinicians.
With medications, the cost of delivery and development go up every year. But TMS is a technology, not a molecule. As with computers, power cells, and other advanced technologies, the costs of TMS decrease every year, while the capabilities go up.
Don is a neuroscientist and entrepreneur with extensive experience in product, neurotechnology, and evangelism. At Ampa, Don is committed to using developments in neuroscience and AI to create breakthroughs in mental health and brain function. His research has been featured on ABC, ESPN, TIME magazine, and The Economist. Over a million people have viewed his TEDx talk “neurohacking: rewiring your brain.” He has been an opinion leader for a range of news outlets including The Wall Street Journal and The Economist. Don completed dual degrees from Stanford—a B.S. in Physics and a B.A. in Economics—and a Ph.D. in Neuroscience from UCLA.
Outside of Ampa, Dr. Jonathan Downar is an Adjunct Professor in the Department of Psychiatry and Institute of Medical Science at the University of Toronto.Over the last quarter-century, he has published over 180 peer-reviewed articles on brain imaging and on TMS, in journals including Lancet, Nature Medicine, Nature Neuroscience, JAMA Psychiatry, and the American Journal of Psychiatry. He is the senior author of the landmark THREE-D study, demonstrating that TMS treatments could be reduced from 38 min sessions to 3 minute sessions with no loss of efficacy. Dr. Downar’s work focuses on translating neuroscience breakthroughs into practical treatment tools that can help people around the world recover from mental health disorders.
© 2025 Ampa Inc. All rights reserved.
